Biological Products, (No Diagnostic Substances)·CHARLESTOWN, MA
Financials
20 shown
Type
Period
Ended
Filed
10-Q
Q3 2025
9/30/25
11/3/25
→
10-Q
Q2 2025
6/30/25
8/12/25
→
10-Q
Q1 2025
3/31/25
5/15/25
→
10-K
FY 2024
12/31/24
3/6/25
→
10-Q
Q3 2024
9/30/24
11/6/24
→
10-Q
Q2 2024
6/30/24
8/13/24
→
↓
Earnings Releases (8-K)
21 shown
Filed
Period
3/6/26
Q1 FY2026
→
11/3/25
Q4 FY2025
→
2/18/25
Q1 FY2025
→
1/8/24
Q4 FY2024
→
1/9/23
Q4 FY2023
→
8/11/22
Q3 FY2022
→
↓
News (8-K)
43 shown
Filed
Type
Description
6/13/25
Exec Change
Departure or Appointment of Directors or Certain Officers
→
5/15/25
Other
Other Events
→
2/18/25
Agreement
Entry into a Material Definitive Agreement
→
2/18/25
Other
Other Events
→
6/11/24
Exec Change
Departure or Appointment of Directors or Certain Officers
→
11/15/23
Reg FD
Regulation FD Disclosure
→
↓
Prospectuses & Registrations
40 shown
Filed
Form
Description
6/13/25
S-8
S-8
→
5/15/25
424B5
424B5
→
5/15/25
S-3
S-3
→
4/25/25
ARS
ARS
→
3/6/25
S-3
S-3
→
3/6/25
S-3
S-3
→
↓
Filing History(680 filings)
TypeDateAccessionPeriodSize
8-K
Mar 6, 2026
0001193125-26-0967098-K
Mar 6, 2026
622.2 KB
4
Feb 18, 2026
0001193125-26-0578784
Feb 13, 2026
9.1 KB
144
Feb 18, 2026
0001193125-26-057874
—
6.0 KB
144
Feb 18, 2026
0001193125-26-057873
—
6.7 KB
4
Feb 18, 2026
0001193125-26-0578724
Feb 13, 2026
9.1 KB
144
Feb 18, 2026
0001193125-26-057871
—
6.7 KB
4
Feb 18, 2026
0001193125-26-0578684
Feb 13, 2026
11.1 KB
144
Feb 18, 2026
0001193125-26-057867
—
6.7 KB
144
Feb 18, 2026
0001193125-26-057866
—
6.7 KB
4
Feb 18, 2026
0001193125-26-0578654
Feb 13, 2026
9.1 KB
4
Feb 18, 2026
0001193125-26-0578634
Feb 13, 2026
9.2 KB
144
Feb 18, 2026
0001193125-26-057862
—
6.7 KB
4
Feb 18, 2026
0001193125-26-0578594
Feb 13, 2026
9.1 KB
144
Feb 18, 2026
0001193125-26-057858
—
6.6 KB
4
Feb 18, 2026
0001193125-26-0578554
Feb 13, 2026
9.1 KB
SCHEDULE 13G
Feb 17, 2026
0000902664-26-001082
—
14.6 KB
SCHEDULE 13G/A
Feb 12, 2026
0000902664-26-000908
—
12.3 KB
4
Feb 6, 2026
0001193125-26-0415234
Feb 4, 2026
5.4 KB
4
Feb 6, 2026
0001193125-26-0415194
Feb 4, 2026
5.4 KB
4
Feb 6, 2026
0001193125-26-0415164
Feb 4, 2026
7.1 KB
4
Feb 6, 2026
0001193125-26-0415144
Feb 4, 2026
5.3 KB
4
Feb 6, 2026
0001193125-26-0415114
Feb 4, 2026
5.4 KB
4
Feb 6, 2026
0001193125-26-0415074
Feb 4, 2026
5.4 KB
4
Feb 6, 2026
0001193125-26-0415064
Feb 4, 2026
5.4 KB
144
Feb 4, 2026
0001193125-26-038037
—
5.9 KB
25 filings shown
Solid Biosciences Inc. — SlamSEC
Proxies
22 shown
Filed
Form
Description
4/25/25
DEFA14A
DEFA14A
→
4/25/25
DEF 14A
DEF 14A
→
4/11/25
PRE 14A
PRE 14A
→
4/26/24
DEFA14A
DEFA14A
→
4/26/24
DEF 14A
DEF 14A
→
4/12/24
PRE 14A
PRE 14A
→
↓
Ownership
40 shown
Filed
Form
Description
2/18/26
4
4
→
2/18/26
4
4
→
2/18/26
4
4
→
2/18/26
4
4
→
2/18/26
4
4
→
2/18/26
4
4
→
↓
Other Filings
40 shown
Filed
Form
Description
2/18/26
144
144
→
2/18/26
144
144
→
2/18/26
144
144
→
2/18/26
144
144
→
2/18/26
144
144
→
2/18/26
144
144
→
↓
Solid is a state of matter in which atoms are closely packed and are difficult to move past each other. Solids resist compression, expansion, or external forces that would alter its shape, with the degree of resistance being dependent upon the specific material under consideration.